JV-1-36 is a growth hormone-releasing hormone (GHRH) antagonist. JV-1-36 inhibits the production of reactive oxygen species in A549 lung cancer cells. JV-1-36 can be used to study the effect of GHRH antagonists in vitro [1].
Molecular Weight:
3785.88
CAS Number:
[221377-79-3]
Formula:
C172H284ClN53O41
Target:
GHSR
Application Notes:
MCE Product type: Peptides
* VAT and and shipping costs not included. Errors and price changes excepted